Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gregg S. Wilkinson is active.

Publication


Featured researches published by Gregg S. Wilkinson.


European Journal of Cancer. Part B: Oral Oncology | 1992

Smoking, alcohol, dentition and diet in the epidemiology of oral cancer

James R. Marshall; Saxon Graham; Brenda P. Haughey; Donald Shedd; Robert M. O'Shea; John Brasure; Gregg S. Wilkinson; Dee W. West

This matched case-control study was conducted in Western New York. The smoking, alcohol consumption, dental hygiene and diet of 290 cases were compared with those of 290 sex-, age-, and neighbourhood-matched controls. The results confirm earlier findings that cigarette smoking and alcohol consumption impart substantial risk of oral cancer. The results also confirm that poor oral hygiene increases the risk of oral cancer, although this effect is much smaller than those of cigarette smoking and alcohol consumption. The results suggest that, of macronutrients, intake of fat is more likely than those of protein or carbohydrate to be related to risk. Of micronutrients, calcium, sodium, riboflavin and retinol are associated with risk, while thiamin, niacin, and dietary fibre are associated with decreased risk. Although patterns of dietary effects are discernable, these effects are in general much weaker than are those of smoking and alcohol consumption.


American Journal of Obstetrics and Gynecology | 1991

Drug abuse and other risk factors for physical abuse in pregnancy among white non-Hispanic, black, and Hispanic women

Abbey B. Berenson; Norma J. Stiglich; Gregg S. Wilkinson; Garland D. Anderson

We investigated prevalence and risk factors associated with physical abuse among a tricultural population of 501 pregnant women who attended a public prenatal clinic. Twenty percent (98/501) reported being physically abused; 29% (28/98) stated that abuse occurred during pregnancy. More white non-Hispanic women reported previous abuse than did black or Hispanic women. Battered women more frequently were divorced or separated, were of greater parity, smoked, used alcohol, or admitted to illicit drug use than did women who were not battered. An increased risk of previous physical abuse was observed among white non-Hispanic and black women who used alcohol (odds ratios = 3.0 and 6.0) or drugs (odds ratios = 2.1 and 3.7) but not among Hispanic women. Odds ratios of 4.7 for cocaine use among white non-Hispanic women, 4.7 for marijuana use among black women, and 5.8 for tobacco use among Hispanic women were observed. This is the first study to report the effects of race on the association between physical abuse of pregnant women and substance use.


JAMA Pediatrics | 2014

Trends in Otitis Media–Related Health Care Use in the United States, 2001-2011

Tal Marom; Alai Tan; Gregg S. Wilkinson; Karen S. Pierson; Jean L. Freeman; Tasnee Chonmaitree

IMPORTANCE Otitis media (OM) is a leading cause of pediatric health care visits and the most frequent reason children consume antibiotics or undergo surgery. During recent years, several interventions have been introduced aiming to decrease OM burden. OBJECTIVE To study the trend in OM-related health care use in the United States during the pneumococcal conjugate vaccine (PCV) era (2001-2011). DESIGN, SETTING, AND PARTICIPANTS An analysis of an insurance claims database of a large, nationwide managed health care plan was conducted. Enrolled children aged 6 years or younger with OM visits were identified. MAIN OUTCOMES AND MEASURES Annual OM visit rates, OM-related complications, and surgical interventions were analyzed. RESULTS Overall, 7.82 million unique children (5.51 million child-years) contributed 6.21 million primary OM visits; 52% were boys and 48% were younger than 2 years. There was a downward trend in OM visit rates from 2004 to 2011, with a significant drop that coincided with the advent of the 13-valent vaccine (PCV-13) in 2010. The observed OM visit rates in 2010 (1.00/child-year) and 2011 (0.81/child-year) were lower than the projected rates based on the 2005-2009 trend had there been no intervention (P < .001). Recurrent OM (≥3 OM visits within 6-month look-back) rates decreased at 0.003/child-year (95% CI, 0.002-0.004/child-year) in 2001-2009 and at 0.018/child-year (95% CI, 0.008-0.028/child-year) in 2010-2011. In the PCV-13 premarket years, there was a stable rate ratio (RR) between OM visit rates in children younger than 2 years and in those aged 2 to 6 years (RR, 1.38; 95% CI, 1.38-1.39); the RR decreased significantly (P < .001) during the transition year 2010 (RR 1.32; 95% CI, 1.31-1.33) and the postmarket year 2011 (RR 1.01; 95% CI, 1.00-1.02). Tympanic membrane perforation/otorrhea rates gradually increased (from 3721 per 100,000 OM child-years in 2001 to 4542 per 100,000 OM child-years in 2011; P < .001); the increase was significant only in the older children group. Mastoiditis rates substantially decreased (from 61 per 100,000 child-years in 2008 to 37 per 100,000 child-years in 2011; P < .001). Ventilating tube insertion rate decreased by 19% from 2010 to 2011 (P = .03). CONCLUSIONS AND RELEVANCE There was an overall downward trend in OM-related health care use from 2001 to 2011. The significant reduction in OM visit rates in 2010-2011 in children younger than 2 years coincided with the advent of PCV-13. Although tympanic membrane perforation/otorrhea rates steadily increased during that period, mastoiditis and ventilating tube insertion rates decreased in the last years of the study.


Journal of Adolescent Health | 1992

Prevalence of physical and sexual assault in pregnant adolescents

Abbey B. Berenson; J.D. Virginia V. San Miguel; Gregg S. Wilkinson

Few studies have addressed the prevalence of violence among pregnant adolescents. We interviewed 342 pregnant teenagers 17 years of age or younger for a history of assault; 9% reported physical assault, 8% sexual assault, and 8% both physical and sexual assault. Of those physically abused, 40% had been hit during pregnancy. The most common perpetrator of physical assault was a member of their family of origin as compared to a mate (46% versus 33%), although a boyfriend or spouse was the attacker in 80% of cases in which abuse had increased during pregnancy. The face or neck was the most common site of contact. A total of 14% reported being hit in the abdomen, one-third of them while pregnant. We conclude that a significant proportion of pregnant teenagers have experienced violence and therefore should be screened routinely for a history of abuse.


Nutrition and Cancer | 1992

Diet, smoking, and alcohol in cancer of the larynx : a case-control study

Jo L. Freudenheim; Saxon Graham; Tim Byers; James R. Marshall; Brenda P. Haughey; Mya Swanson; Gregg S. Wilkinson

A case-control study among white men in western New York was conducted from 1975 through 1985 to examine diet and other risk factors for laryngeal cancer. Incident pathologically confirmed cases (250) and age- and neighborhood-matched controls (250) were interviewed to determine usual diet and lifetime use of tobacco and alcohol. Cigarettes were strongly associated with risk; pipes and cigars were not. Beer and hard liquor but not wine were associated with increased risk. Dietary fat and carotenoids were related to risk in opposite ways. The upper quartile odds ratio for dietary fat was 2.40 [95% confidence interval 1.26, 4.55], and the upper quartile odds ratio for carotenoids was 0.51 (0.26, 1.01). There was effect modification by smoking. Carotenoids were most negatively associated with risk among the lightest smokers, whereas dietary fat was most positively associated with risk among the heaviest smokers. Total calories, protein, and retinol were associated with increased risk; there was no relationship between laryngeal cancer and vitamin C, vitamin E, carbohydrate, or dietary fiber. This study again demonstrates the strong association between tobacco and alcohol and laryngeal cancer and also suggests that diets low in carotenoids and high in fat may increase risk.


Obstetrics & Gynecology | 2009

Effect of injectable and oral contraceptives on serum lipids

Abbey B. Berenson; Mahbubur Rahman; Gregg S. Wilkinson

OBJECTIVE: To estimate the effects of using depot medroxyprogesterone acetate (DMPA) or oral contraceptives (OCs) containing 20 micrograms ethinyl estradiol and 0.15 mg desogestrel on serum lipid levels. METHODS: Serum lipids were measured at baseline and every 6 months thereafter for 3 years in 703 white, African-American, and Hispanic women using DMPA, OC, or nonhormonal birth control. Those who discontinued DMPA were followed for up to 2 additional years. Participants completed questionnaires containing demographic and behavioral measures every 6 months and underwent 24-hour dietary recalls annually. Mixed-model regression analyses and general-estimating-equations procedures were used to estimate changes over time in lipids by method along with their predictors. RESULTS: Users of OCs experienced significantly greater increases in levels of triglycerides, total cholesterol, very-low-density lipoprotein (VLDL) cholesterol, and high-density lipoprotein (HDL) cholesterol than did nonhormonal-contraceptive users (P<.001). However, no difference was noted in the low-density lipoprotein (LDL) cholesterol:HDL ratio between OC users and nonhormonal-contraceptive users. Among DMPA users, HDL levels initially decreased for 6 months but then returned to baseline. The LDL:HDL ratio rose in the first 6 months of DMPA use but then dropped back to baseline over the next 24 months. After DMPA was discontinued, triglyceride, VLDL, and HDL levels were significantly higher in women who used OCs than in those who chose nonhormonal (P<.05) methods. CONCLUSION: Use of very-low-dose OCs containing desogestrel can elevate lipid levels. Users of DMPA were at increased risk of developing an abnormally low HDL level as well as an abnormally high LDL level and an increase in the LDL:HDL cholesterol ratio, although these effects appeared to be temporary. LEVEL OF EVIDENCE: II


Obstetrics & Gynecology | 2013

Complications and continuation of intrauterine device use among commercially insured teenagers.

Abbey B. Berenson; Alai Tan; Jacqueline M. Hirth; Gregg S. Wilkinson

OBJECTIVE: Many U.S. health care providers remain reluctant to prescribe intrauterine devices (IUDs) to teenagers as a result of concerns about serious complications. This study examined whether 15–19-year-old IUD users were more likely to experience complications, failure, or early discontinuation than adult users aged 20–24 years and 25–44 years and whether there were differences in these outcomes between users of levonorgestrel-releasing intrauterine systems and copper IUDs. METHODS: A retrospective cohort study was conducted using health insurance claims obtained from a private insurance company of 90,489 women who had an IUD inserted between 2002 and 2009. Logistic regression models were used to estimate the odds of experiencing complications, method failure, or early discontinuation within 12 months of insertion by age group and type of IUD inserted. RESULTS: Serious complications, including ectopic pregnancy and pelvic inflammatory disease, occurred in less than 1% of patients regardless of age or IUD type. Women aged 15–19 years were more likely than those aged 25–44 years to have a claim for dysmenorrhea (odds ratio [OR] 1.4, confidence interval [CI] 1.1–1.6), amenorrhea (OR 1.3, CI 1.1–1.5), or normal pregnancy (OR 1.4, CI 1.1–1.8). Overall, early discontinuation did not differ between teenagers and women aged 25–44 years (13% compared with 11%, P>.05). However, use of the levonorgestrel-releasing intrauterine system was associated with fewer complications and less early discontinuation than the copper IUD in all age groups. CONCLUSIONS: The IUD is as appropriate for teenagers to use as it is for older women, with serious complications occurring infrequently in all groups. The levonorgestrel-releasing intrauterine system may be a better choice than the copper IUD as a result of lower odds of complications, discontinuation, and failure. LEVEL OF EVIDENCE: II


Journal of Clinical Oncology | 2010

Atrial Fibrillation and Stroke Associated With Intravenous Bisphosphonate Therapy in Older Patients With Cancer

Gregg S. Wilkinson; Jacques Baillargeon; Yong Fang Kuo; Jean L. Freeman; James S. Goodwin

PURPOSE Recent studies have linked the use of intravenous and orally administered bisphosphonates with subsequent development of atrial fibrillation. Patients with cancer who receive intravenous bisphosphonate therapy may be at particular risk for this adverse event because they receive higher doses of these drugs than do patients treated for other indications. We examined the association of intravenous bisphosphonates with atrial fibrillation, all classifications of supraventricular tachycardia (SVT), and stroke among older patients with cancer. PATIENTS AND METHODS Using Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked data, we identified older (≥ age 65 years) patients with cancer who were treated with intravenous infusions of bisphosphonates between January 1, 1995 and December 31, 2003. We then matched 13,714 bisphosphonate nonusers to 6,857 bisphosphonate users, at a 2:1 ratio, on cancer type, age, sex, presence of bone metastases, and SEER geographic region. Patients were observed until December 31, 2003 or until they lost coverage from Medicare Parts A and B; enrolled in a health maintenance organization; received a diagnosis of atrial fibrillation, any SVT, or stroke; or died. RESULTS Receipt of intravenous bisphosphonates was modestly associated with an increased risk for atrial fibrillation (hazard ratio [HR] = 1.30; 95% CI, 1.18 to 1.43), all SVT (HR = 1.28; 95% CI, 1.19 to 1.38), and stroke (HR = 1.30; 95% CI, 1.09 to 1.54). The risk for all SVT increased 7% for each increase of five bisphosphonate dose equivalents (HR = 1.07; 95% CI, 1.02 to 1.12). CONCLUSION Clinicians who treat patients with cancer who have received intravenous bisphosphonates should be aware of the possible cardiovascular adverse events associated with this treatment.


Journal of Adolescent Health | 1992

Violence and its relationship to substance use in adolescent pregnancy

Abbey B. Berenson; Virginia V. San Miguel; Gregg S. Wilkinson

We surveyed 342 pregnant adolescents 17 years old and younger for a history of physical or sexual assault and substance use to investigate whether victims of childhood violence are at increased risk of smoking and using alcohol or drugs. A total of 95% of new patients who attended the universitys teen pregnancy clinic between May 8, 1989, and December 8, 1990, were interviewed. Substance use was reported seven times more often in those with a history of combined physical and sexual assault, five times more frequently by those who had been sexually assaulted, and three times more often in those who had been physically assaulted than adolescents without a history of assault. Violence was associated with substance use in all ethnic groups although this relationship was modified by ethnicity. Among Hispanics, an association was observed between physical assault and tobacco use. Sexual and combined physical and sexual assault were strongly associated with use of alcohol among blacks. All categories of violence were associated with drug use among all ethnic groups. When use of each substance was analyzed by the adolescents relationship to the perpetrator, drug use was most strongly associated with assault by a mate, whereas tobacco or alcohol use was more often associated with assault by a member of the victims family of origin.


Cancer | 2012

Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009

Jacqueline M. Hirth; Alai Tan; Gregg S. Wilkinson; Abbey B. Berenson

Completion of the human papillomavirus (HPV) vaccine in a large percentage of young females is an important goal to prevent anogenital cancers associated with HPV. The current study examined whether the percentage of insured women who complete the vaccine series has changed across time, and how provider type and age at initiation affects rates of completion.

Collaboration


Dive into the Gregg S. Wilkinson's collaboration.

Top Co-Authors

Avatar

Abbey B. Berenson

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Alai Tan

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Gary L. Tietjen

Los Alamos National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Jacques Baillargeon

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Yong Fang Kuo

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

George L. Voelz

Los Alamos National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Jacqueline M. Hirth

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

James S. Goodwin

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar

Jean L. Freeman

University of Texas Medical Branch

View shared research outputs
Researchain Logo
Decentralizing Knowledge